Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMED5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPR89A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNNC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100294033 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAN1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WRAP53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPS1-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BCCIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf168 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UFSP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMMR-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR82 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on